⌘K
Loading ticker…
As of 2026-08-24, Agenus Inc. (AGEN) has a 3-month relative strength percentile of 99 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 83. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.2%, relative volume 0.47×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AGEN is in a stage 2 uptrend, week 2. Currently in a 14-day base; basing ADR 9.2% (broad 9.0%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 42.5% / 89.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
AGEN is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Held by 3 ETFs · $5M across latest filings · largest weight 0.02% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M | — |
| VXFVanguard Extended Market ETF | 0.00% | $1M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AGEN Jan avg: 4.62% median: -0.40% win: 50% σ: 25.53% n: 4 2022-04-12 → 2026-07-31 | AGEN Feb avg: -7.10% median: -10.33% win: 50% σ: 19.71% n: 4 2022-04-12 → 2026-07-31 | AGEN Mar avg: -21.63% median: -19.82% win: 25% σ: 20.19% n: 4 2022-04-12 → 2026-07-31 | AGEN Apr avg: 18.60% median: 4.48% win: 60% σ: 43.15% n: 5 2022-04-12 → 2026-07-31 | AGEN May avg: 6.25% median: 3.31% win: 60% σ: 17.59% n: 5 2022-04-12 → 2026-07-31 | AGEN Jun avg: 9.23% median: 6.76% win: 80% σ: 16.96% n: 5 2022-04-12 → 2026-07-31 | AGEN Jul avg: 25.99% median: 20.79% win: 60% σ: 76.34% n: 5 2022-04-12 → 2026-07-31 | AGEN Aug avg: -10.89% median: -11.97% win: 25% σ: 12.09% n: 4 2022-04-12 → 2026-07-31 (current) | AGEN Sep avg: -10.92% median: -13.00% win: 25% σ: 13.34% n: 4 2022-04-12 → 2026-07-31 | AGEN Oct avg: -6.75% median: -10.12% win: 50% σ: 24.01% n: 4 2022-04-12 → 2026-07-31 | AGEN Nov avg: 0.25% median: 2.35% win: 50% σ: 14.50% n: 4 2022-04-12 → 2026-07-31 | AGEN Dec avg: -13.90% median: -15.50% win: 25% σ: 15.90% n: 4 2022-04-12 → 2026-07-31 |